MedPath

Treatment of Gout with Unani medicine Safoof Chobchini

Phase 3
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2019/02/017821
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

(All of the following)

1. Patients of either sex in the age group of 18-65 years

2. Serum uric acid level: normal or above normal

3. Diagnosed cases of gout as per the ACR/ EULAR-2015 criteria for gout presenting with any of the following symptoms and signs:

4. Joint Pain [especially first metatarsophalangeal (MTP) joint]

5. Tenderness

6. Swelling

7. Redness

Exclusion Criteria

(Any of the following)

1. Clinical conditions involving joints e.g. Osteo-arthritis, Rheumatoid arthritis, Rheumatic arthritis

2. Pregnant and lactating women

3. Patients having any systemic diseases such as hypertension, diabetes mellitus, cardiovascular/cerebrovascular diseases, hepatic and renal disease, osteomalacia, osteoporosis

4. Patients with recent H/O dengue, chikungunya and viral fever

5. Grade-2 obesity (BMI >= 35)

6. Patients on long term medications

7. Patients taking drugs which increase serum uric acid levels (thiazide diuretics, etc.) and decrease serum calcium levels (furosemide, etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath